The analyst rating for CHINA LIFE is influenced by concerns over its 1Q performance, as the market did not expect a loss in the last quarter, leading to negative reactions. Despite this, the company's dividend growth last year met expectations. The firm notes that CHINA LIFE's aggressive investment strategy has resulted in underperformance compared to more conservative peers, and due to macro uncertainties, investors are hesitant to buy high-beta stocks. However, the firm maintains a 'Buy' rating with a target price of HKD33.1.
